Menarini has used its extensive experience with high-performance liquid chromatography (HPLC) technology to provide the most complete HPLC product portfolio on the market, making Menarini the partner of choice for haemoglobin analysis.
The HbNEXT is a ground-breaking addition to Menarini’s portfolio that already includes interference-free HbA1c boronate affinity analysis from the Hb9210 Premier, and cation exchange from the Hb9210 Resolution for haemoglobinopathies.
The HbNEXT uses cation exchange HPLC for haemoglobin analysis with true flexibility. Using the same analytical column and with no reagent change, the operator can with one click and no downtime, switch between HbA1c and haemoglobinopathy chromatography modes. This flexibility means that there is increased confidence in HbA1c analysis and improved workflow in the laboratory.
The HbNEXT achieves high-throughput processing by performing HbA1c analysis in less than one minute and automatically mixes samples by the gold-standard method of inversion. With a coefficient of variation (CV) of 1% and no HbA1c interference from the most common haemoglobin variants, the HbNEXT meets even the most stringent quality guidelines.
